Anti-ischemic effect of a novel cardioprotective agent, JTV519, is mediated through specific activation of δ-isoform of protein kinase C in rat ventricular myocardium

Circulation

Volumn 101, Issue 7, 2000, Pages 797-804

  Inagaki, Koichi ^a   Kihara, Yasuki ^a   Hayashida, Wataru ^a   Izumi, Toshiaki ^a   Iwanaga, Yoshitaka ^a   Yoneda, Takeshi ^a   Takeuchi, Yuzo ^a   Suyama, Katsuo ^a   Muso, Eri ^a   Sasayama, Shigetake ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Immunohistochemistry; Ischemia; JTV519; Pharmacology; Reperfusion

Indexed keywords

4 [3 (4 BENZYL 1 PIPERIDINYL)PROPIONYL] 2,3,4,5 TETRAHYDRO 7 METHOXY 1,4 BENZOTHIAZEPINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; BENZOTHIAZEPINE DERIVATIVE; CARDIOVASCULAR AGENT; ICATIBANT; PRAZOSIN;

ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; HEART MUSCLE ISCHEMIA; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0034701046     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.7.797     Document Type: Article

References (25)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74: 1124-1136.
2. Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol. 1994;266:H1145-H1152.
3. Mitchell MB, Meng X, Ao L, Brown JM, Harken AH, Banerjee A. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res. 1995;76:73-81.
4. 1 stimulation activates δ-protein kinase C in rat ventricular myocytes. Circ Res. 1996;78: 161-165.
5. Brew EC, Mitchell MB, Rehring TF, Gamboni-Robertson F, Mcintyre RC, Harken AH, Banerjee A. Role of bradykininin in cardiac functional protection after global ischemia-reperfusion in rat heart. Am J Physiol. 1995; 269:H1370-H1378.
6. Kaneko N. New 1,4-benzothiazepine derivative, K201, demonstrates cardioprotective effects against sudden cardiac cell death and intracellular calcium blocking action. Drug Dev Res. 1994;33:429-438.
7. Morii I, Kihara Y, Inoko M, Sasayama S. Myocardial contractile efficiency and oxygen cost of contractility are preserved during transition from compensated hypertrophy to failure in rats with salt-sensitive hypertension. Hypertension. 1998;31:949-960.
8. Toullec D, Pianett P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, Duhamel L, Charton D, Kirilovsky J. The bisindolylmaleimide GF109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem. 1991;266:15771-15781.
9. Rybin VO, Steinberg SF. Protein kinase C isoform expression and regulation in the developing rat heart. Circ Res. 1994;74:299-309.
10. 2+ channel induced by cold acclimation of guinea pig. Am J Physiol. 1998;274:R348-R356.
11. Gray MO, Karliner JS, Mochly-Rosen D. A selective epsilon-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J Biol Chem. 1997;272:30945-30951.
12. 1-Receptor-independent activation of protein kinase C in acute myocardial ischemia: mechanisms for sensitization of the adenylyl cyclase system. Circ Res. 1992;70:1304-1312.
13. Zhao J, Renner O, Wightman L, Sugden PH, Stewart L, Miller AD, Latchman DS, Marber MS. The expression of constitutively active isotypes of protein kinase C to investigate preconditioning. J Biol Chem. 1998;273:23072-23079.
14. Kihara Y, Grossman W, Morgan JP. Direct measurement of changes in intracellular calcium transients during hypoxia, ischemia, and reperfusion of the intact mammalian heart. Circ Res. 1989;65:1029-1044.
15. Kihara Y, Sasayama S, Inoko M, Morgan JP. Sodium/calcium exchange modulates intracellular calcium overload during posthypoxic reoxygenation in mammalian working myocardium: evidence from aequorin-loaded ferret ventricular muscles. J Clin Invest. 1994;93:1275-1284.
16. Morii I, Kihara Y, Konishi T, Inubushi T, Sasayama S. Mechanism of the negative force-frequency relationship in physiologically intact rat ventricular myocardium. Jpn Circ J. 1996;60:593-603.
17. + channel in mediating the effects of acetylcholine to mimic preconditioning in dogs. Circ Res. 1993;73:1193-1201.
18. Schultz JEJ, Rose E, Yao Z, Gross GJ. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol. 1995;268: H2157-H2161.
19. Liu Y, Tsuchida A, Cohen MV, Downey JM. Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J Mol Cell Cardiol. 1995;27:883-892.
20. Wang P, Gallagher KP, Downey JM, Cohen MV. Pretreatment with endothelin-1 mimics ischemic preconditioning against infarction in isolated rabbit heart. J Mol Cell Cardiol. 1996;28:579-588.
21. Hofmann A, Escherich A, Lewit-Bentley A, Benz J, Raguenes-Nicol C, Russo-Marie F, Gerke V, Moroder L, Huber R. Interactions of benzothiazepine derivatives with annexins. J Biol Chem. 1998;273:2885-2894.
22. Dubois T, Oudinet JP, Mira JP, Russo-Marie F. Annexins and protein kinase C. Biochim Biophys Acta. 1996;1313:290-294.
23. Mochly-Rosen D. Localization of protein kinases by anchoring proteins: a theme in signal transduction. Science. 1995;268:247-251.
24. Brunner F, Opie LH. Role of endothelin-A receptors in ischemic contracture and reperfusion injury. Circulation. 1998;97:391-398.
25. Cohen MV, Downey JM. Ischaemic preconditioning: can the protection be bottled? Lancet. 1993;342:6.